From: Long-term prognostic outcomes in patients with haemoptysis
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age (years) | ||||
< 40 | Ref. | Ref. | ||
40–54 | 1.3 (0.4–4.4) | 0.63 | ||
55–70 | 1.6 (0.5–5.0) | 0.41 | ||
> 70 | 1.9 (0.7–5.7) | 0.23 | ||
Sex male | 0.9 (0.6–1.3) | 0.51 | ||
Severity of haemoptysis | ||||
Mild | Ref. | Ref. | ||
Moderate | 1.2 (0.8–2.0) | 0.39 | ||
Severe | 1.2 (0.8–2.0) | 0.35 | ||
Smoking history | ||||
≥ 10 pack/years | 0.7 (0.4–1.1) | 0.09 | ||
≥ 30 pack/years | 0.9 (0.5–1.6) | 0.74 | ||
Antiplatelet therapy | 0.9 (0.5–1.5) | 0.69 | ||
Anticoagulant therapy | 1.1 (0.6–2.2) | 0.75 | ||
Antiplatelet + anticoagulant therapy | 1.0 (0.6–1.6) | 0.98 | ||
Pneumonia/lung abscess | 0.7 (0.4–1.3) | 0.25 | ||
Malignancy (primary and metastatic) | 1.1 (0.6–1.9) | 0.79 | ||
Bronchiectasis | 2.6 (1.5–4.3) | < 0.0001 | ||
Acute bronchitis | 0.6 (0.3–1.3) | 0.18 | ||
Cryptogenic haemoptysis | 1.0 (0.5–2.1) | 0.94 |